NCT01957995View on ClinicalTrials.gov

Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

November 8, 2013

Primary Completion Date

May 29, 2014

Study Completion Date

July 14, 2016

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

nanosomal docetaxel lipid suspension

Given IV

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

90033

USC Norris Comprehensive Cancer Center, Los Angeles

Sponsors

Collaborators (1)

Jina Pharmaceuticals Inc.

All Listed Sponsors

collaborator

Jina Pharmaceuticals Inc.

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER